A pipeline of innovation
Our pipeline demonstrates the different initiatives we are progressing to provide individualized treatments for patients in need.
Development programs under license:
| Program | Partner | ConceptDevelopmentClinicalRegistrationMarketed |
|---|---|---|
| ADHD (Mixed Amphetamine Salts) | Tiefenbacher Group (US) | |
| ADHD (Methylphenidate ) | Undisclosed (EU) | |
| ADHD (Lisdexamfetamine) | Tiefenbacher Group (Global) | |
| Peanut allergy | Camallergy | |
| Anxiety (Psilocybin) | Diamond Therapeutics | |
| Undisclosed | Revio Therapeutics | |
| Undisclosed | Revio Therapeutics | |
| Undisclosed | Revio Therapeutics |
ADHD (Mixed Amphetamine Salts)
Tiefenbacher Group (US)
ConceptDevelopmentClinicalRegistrationMarketed
ADHD (Methylphenidate )
Undisclosed (EU)
ConceptDevelopmentClinicalRegistrationMarketed
ADHD (Lisdexamfetamine)
Tiefenbacher Group (Global)
ConceptDevelopmentClinicalRegistrationMarketed
Peanut allergy
Camallergy
ConceptDevelopmentClinicalRegistrationMarketed
Anxiety (Psilocybin)
Diamond Therapeutics
ConceptDevelopmentClinicalRegistrationMarketed
Undisclosed
Revio Therapeutics
ConceptDevelopmentClinicalRegistrationMarketed
Undisclosed
Revio Therapeutics
ConceptDevelopmentClinicalRegistrationMarketed
Undisclosed
Revio Therapeutics
ConceptDevelopmentClinicalRegistrationMarketed
Collaboration with Tiefenbacher in ADHD
Collaboration with Tiefenbacher in ADHD
Collaboration with Camallergy on Food allergies
Collaboration with Camallergy on Food allergies
Collaboration with Aardex Group